Trials / Completed
CompletedNCT02249936
A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations
A Phase 1, Single-Center, Randomized, 3-Way Cross-Over, Open Label Study to Evaluate the Pharmacodynamics of Different Formulations of AZD1722 in Healthy Volunteers Taking Omeprazole
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Ardelyx · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study is designed to evaluate safety, tolerability, pharmacodynamics and pharmacokinetics of different formulations of AZD1722 in healthy male and female subjects taking Omeprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD1722 | |
| DRUG | Omeprazole |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2014-09-26
- Last updated
- 2014-09-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02249936. Inclusion in this directory is not an endorsement.